Localization and level of expression of beta-catenin in human laryngeal squamous cell carcinoma

Otolaryngol Head Neck Surg. 2004 Jan;130(1):89-93. doi: 10.1016/j.otohns.2003.09.003.

Abstract

Objective: We studied the participation of beta-catenin in the histologic differentiation of laryngeal squamous cell carcinomas.

Study design and setting: At the National Institute of Respiratory Diseases, a tertiary referral center, localization and level of expression of beta-catenin were compared between normal epithelium (15 cases) and primary tumors in different degrees of differentiation (38 cases), using an immunohistochemical procedure.

Results: Cell membrane staining of beta-catenin was observed in normal epithelium and in well and moderately differentiated carcinomas. Cytoplasmic redistribution was observed in poorly differentiated carcinomas. Loss of beta-catenin correlated with tumor dedifferentiation.

Conclusion: Reduction of cell membrane beta-catenin expression correlated with tumor dedifferentiation.

Significance: Loss of beta-catenin may lead to diminishing the strength of the intercellular adhesion system, thereby promoting the invasive phenotype of the squamous cell carcinoma of the larynx.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Cell Membrane / metabolism
  • Cell Transformation, Neoplastic / metabolism*
  • Cell Transformation, Neoplastic / pathology
  • Cytoskeletal Proteins / metabolism*
  • Humans
  • Immunohistochemistry
  • Laryngeal Neoplasms / metabolism*
  • Laryngeal Neoplasms / pathology
  • Trans-Activators / metabolism*
  • beta Catenin

Substances

  • CTNNB1 protein, human
  • Cytoskeletal Proteins
  • Trans-Activators
  • beta Catenin